Table 2.
Association between chemotherapeutic response and clinical characteristics
| Variables | Chemotherapeutic response | P value | |
|---|---|---|---|
| Chemosensitive(n = 112) | Chemoresistance(n = 57) | ||
| Age (year) | 0.923 | ||
| <50 | 50 | 25 | |
| ≥ 50 | 62 | 32 | |
| FIGO stage | 0.665 | ||
| I-II | 31 | 14 | |
| III-IV | 81 | 43 | |
| Histological grade | 0.001 | ||
| Low | 19 | 23 | |
| High | 93 | 34 | |
| Lymph node invasion | 0.550 | ||
| Negative | 89 | 43 | |
| Positive | 23 | 14 | |
| Tumor residual (cm) | 0.286 | ||
| Optimal(≤1) | 87 | 40 | |
| Sub-optimal(>1) | 25 | 17 | |
| CA125 level (U/mL) | 0.729 | ||
| ≤ 35 | 9 | 3 | |
| >35 | 103 | 54 | |
| Severity of CIN | <0.001 | ||
| Absence | 1 | 15 | |
| Mild | 81 | 34 | |
| Sever | 30 | 8 | |
| Timing of CIN | <0.001 | ||
| Early onset | 99 | 10 | |
| Non-early onset | 13 | 47 | |